Skip to content
AlphaFlo® Canine Allograft - Offical Logo
  • Home
  • About
    • About Us
    • Key Opinion Leader
  • AlphaFlo
    • Product
    • FAQs
    • Senior Canine Wellness
    • Testimonials
  • Case Studies
  • News
  • Find a Vet
  • Testimonials
    • Pet Parent Stories 
    • Vet Testimonials 
  • Order
  • Contact
Order
AlphaFlo® Canine Allograft - Offical Logo
  • Home
  • About
    • About Us
    • Key Opinion Leader
  • AlphaFlo
    • Product
    • FAQs
    • Senior Canine Wellness
    • Testimonials
  • Case Studies
  • News
  • Find a Vet
  • Testimonials
    • Pet Parent Stories 
    • Vet Testimonials 
  • Order
  • Contact
What Makes Amniotic Tissue Anti-Fibrotic? A Closer Look at TIMP-2

What Makes Amniotic Tissue Anti-Fibrotic? A Closer Look at TIMP-2

by Heather Frigaard | Jun 25, 2026 | News

Fibrosis, the formation of excess fibrous connective tissue in response to injury or chronic inflammation, is a process that veterinarians encounter across a range of canine cases. Amniotic tissue has been studied for its reported anti-fibrotic properties, and...
What Makes Amniotic Tissue Anti-Inflammatory? A Closer Look at A2M, IL-1ra, and IL-10

What Makes Amniotic Tissue Anti-Inflammatory? A Closer Look at A2M, IL-1ra, and IL-10

by Heather Frigaard | Jun 25, 2026 | News

When veterinarians evaluate regenerative options for their canine patients, understanding what is inside the product matters. AlphaFlo® is a liquid, cryopreserved, acellular canine amniotic tissue allograft used to supplement and protect canine tissues. Amniotic...
Why AlphaFlo® Has Become a Meaningful Part of My Clinical Approach

Why AlphaFlo® Has Become a Meaningful Part of My Clinical Approach

by Heather Frigaard | May 19, 2026 | News

By Bree Valensin, DVM In veterinary medicine, no two cases are the same. Every patient, every family, and every clinical situation comes with its own set of variables and that reality shapes how I think about the options I offer in practice. For me, AlphaFlo® fits...
Clinical Case: Management of Myelofibrosis With Serial Hematologic Monitoring

Clinical Case: Management of Myelofibrosis With Serial Hematologic Monitoring

by AlphaFlo Canine | Feb 16, 2026 | Case Studies

Thomas Newland, DVM Adobe Animal Hospital | Scottsdale, AZ   Case Overview I evaluated a young, 10-month-old mini dachshund referred for ongoing management of severe, persistent, non-regenerative anemia that had not shown durable response to prior medical...
Clinical Case: Bilateral Supraspinatus Tenosynovitis With Calcification and Functional Improvement at One and Three Months

Clinical Case: Bilateral Supraspinatus Tenosynovitis With Calcification and Functional Improvement at One and Three Months

by AlphaFlo Canine | Feb 5, 2026 | Case Studies

Thomas Newland, DVM Adobe Animal Hospital | Scottsdale, AZ Case Overview I evaluated a 3-year-old, female Labrador Retriever weighing 76 lbs. that presented for chronic forelimb lameness associated with activity. The dog had a history of intermittent improvement with...
« Older Entries
Next Entries »

Learn More

  • Case Studies
  • News
  • Press Releases
  • Testimonials

Have questions for us or are you ready to place an order?

Talk To Our Team
AlphaFlo Logo

AlphaFlo® is an advancement in canine regenerative medicine intended to supplement and protect canine tissues.

Subscribe to Our Emails

Quick Links

  • Benefits
  • About
  • Order
  • Contact
  • Distributors

Policies

  • Privacy Policy
  • Terms of Use
Copyright © | AlphaLogix, LLC.
AlphaFlo® is a Registered Trademark of AlphaLogix, LLC.
  • Follow
  • Follow
  • Follow
  • Follow